Llwytho...
New Treatment Options for Metastatic Thyroid Cancer
Newer multitargeted kinase inhibitors show prolonged overall and progression-free survival in patients with metastatic differentiated and medullary thyroid cancers.
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Fed Pract |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Frontline Medical Communications Inc.
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6375431/ https://ncbi.nlm.nih.gov/pubmed/30766126 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|